Talk:Peptide aggregation

Discussion page·3 threads·no archives

This is the discussion page for the article Peptide aggregation. It is for improving the article: sources, wording, structure, scope and titles. It is not a general discussion forum about the subject, and it is not a place to ask for advice — see Project:Medical disclaimer.

Reversible versus irreversibleResolved

Conflating self-association with fibrillation is endemic. Opening with the liraglutide and amylin contrast fixes it in one paragraph. — StabilityStig (talk) 10:20, 17 January 2026 (UTC)

And both examples are real and well documented, which is better than an abstract statement of the distinction. ✓ Done — AmylinAmos (talk) 13:55, 17 January 2026 (UTC)

Resolved. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

RP-HPLC blind to aggregationDone

The point that aggregates dissociate on a reverse-phase column and are counted as monomer is the single most consequential thing here for anyone reading a certificate. — Chromatokid (talk) 09:45, 11 April 2026 (UTC)

It is in the table and in the prose immediately after. I would resist trimming either. ✓ Done — Areapercent_Ayo (talk) 13:20, 11 April 2026 (UTC)

Done. This thread is closed. Reopening it is fine if new sources appear; please add a new subsection rather than editing the closed discussion.

Handling practices

The handling paragraph is close to instruction. It is framed as following from mechanism, which I think is acceptable in a scientific article, but it should not grow. — NPOV_Nadia (talk) 11:30, 5 June 2026 (UTC)

Agreed. Anything further belongs at Reconstitution of lyophilised peptides, where the framing is already settled. — LyophilLena (talk) 15:00, 5 June 2026 (UTC)

This page was last edited on 5 June 2026, by LyophilLena. Text is available under the PeptidePedia Wiki Content Licence (PPCL-BY-SA 4.0).